Orchid Chemicals Gets USFDA Nod For Levofloxacin Tablets (03-Feb-2012)
Chennai-based global pharma major, Orchid Chemicals & Pharmaceuticals (Orchid Chemicals) has received an approval from the USFDA for its abbreviated new drug application (ANDA) for Levofloxacin tablets in the 250mg, 500mg and 750mg strengths.
Recently, the company had successfully completed in Europe a Phase-I trial of its orally administered phosphodiesterase 4 inhibitor (PDE4) molecule OCID 2987 positioned for the treatment of inflammatory disorders including chronic obstructive pulmonary disease (COPD).
Orchid Chemicals & Pharmaceuticals is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was incorporated in the year 1992 as a 100% export-oriented unit (EOU).
Top News Today
 National Thermal Power Corporation (NTPC) will be signing the fuel supply agreements' (FSA) with Coal India for 4,300 megawatts on 2009 terms. In these FSAs companies have change trigger level, which has
 After cellular market leader Bharti Airtel launched its 4G services, now Reliance Industries is reportedly gearing up to launch the services soon and has accordingly partnered with Himachal Futuristic
 Wipro's IT, consulting and outsourcing business Wipro Technologies is likely to introduce India Gateway internship programme for UK university students in July 2012. This internship program consists of
|
International Stock News
 US markets got a good bounce back on Monday with all major indices gaining more than 1%, it was one of the best session of the month. There was some M&A activity along with report that Chinese government
 US markets declined further on Friday, making it the worst week for the markets in 2012, as the most awaited Facebook (FB) IPO was only able to muster a slight gain in its public debut, while the eurozone
 Thursday proved another bad day for the US markets with major indices losing over one to two percent as eurozone debt contagion worries continued, coupled with disappointing economy news. A read on manufacturing
|
|
Recent Corporate-World News
|
|